Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow

Endocrinology. 1997 Oct;138(10):4456-62. doi: 10.1210/endo.138.10.5425.

Abstract

We have investigated the effects of different growth factors on the proliferation and osteogenic potential of primary cultures of human bone marrow stromal cells (BMSC). Fibroblast growth factor (FGF)-2 was the most effective in promoting growth of these cells in vitro. The size of colonies formed in clonal conditions was approximately 2.5 times larger in presence of FGF-2. Also the morphology of BMSC was affected: cells cultured in 10% FCS alone became flattened, whereas FGF-2 expanded cells maintained a fibroblast-like elongated phenotype. Levels of alkaline phosphatase activity in BMSC expanded with FGF-2 were significantly lower (56%) than control and, after stimulation with ascorbic acid, betaGlycerophosphate and dexamethasone, FGF-2 expanded BMSC deposited approximately 3-fold more mineralized matrix than control cells. We have assessed osteogenicity of BMSC on hydroxyapatite porous scaffolds (bioceramics) by an ectopic bone formation assay. FGF-2 expanded BMSC yielded a higher bone formation (>20-fold) than control cells. We conclude that FGF-2, promoting BMSC proliferation, maintains cells in a more immature state allowing in vitro expansion of human osteo-progenitors which, associated with bioceramics, can differentiate in vivo and form bone tissue.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alkaline Phosphatase / analysis
  • Ascorbic Acid / pharmacology
  • Bone Marrow / drug effects
  • Bone Marrow / enzymology
  • Bone Marrow Cells*
  • Cell Division / drug effects
  • Cell Division / physiology
  • Cells, Cultured
  • Child
  • Dexamethasone / pharmacology
  • Epidermal Growth Factor / pharmacology
  • Fibroblast Growth Factor 2 / pharmacology*
  • Fibroblasts / cytology
  • Fibroblasts / drug effects
  • Fibroblasts / enzymology
  • Glycerophosphates / pharmacology
  • Growth Hormone / pharmacology
  • Growth Substances / pharmacology
  • Humans
  • Insulin-Like Growth Factor I / pharmacology
  • Platelet-Derived Growth Factor / pharmacology
  • Stem Cells / cytology*
  • Stem Cells / drug effects
  • Stem Cells / enzymology
  • Transforming Growth Factor beta / pharmacology

Substances

  • Glycerophosphates
  • Growth Substances
  • Platelet-Derived Growth Factor
  • Transforming Growth Factor beta
  • Fibroblast Growth Factor 2
  • Epidermal Growth Factor
  • Insulin-Like Growth Factor I
  • Dexamethasone
  • Growth Hormone
  • Alkaline Phosphatase
  • Ascorbic Acid